Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TSBX

Turnstone Biologics (TSBX) Stock Price, News & Analysis

Turnstone Biologics logo

About Turnstone Biologics Stock (NASDAQ:TSBX)

Key Stats

Today's Range
$0.36
$0.36
50-Day Range
$0.35
$0.37
52-Week Range
$0.29
$2.42
Volume
N/A
Average Volume
142,319 shs
Market Capitalization
$8.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.45
Consensus Rating
Reduce

Company Overview

Receive TSBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Turnstone Biologics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TSBX Stock News Headlines

Why Peter Thiel Hid Gold in a Vault
Silicon Valley billionaires hiding gold in vaults? Peter Thiel’s Palantir quietly diverted tens of millions into gold and locked it away. They called it preparation for a “black swan.” But the real reason may be this: “The Golden Swan” Indicator just hit its highest level ever — 209%.tc pixel
Turnstone Biologics Corp. (TSBX) - Yahoo Finance
See More Headlines

TSBX Stock Analysis - Frequently Asked Questions

Turnstone Biologics Corp. (NASDAQ:TSBX) posted its quarterly earnings results on Friday, August, 8th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by $0.08.

Turnstone Biologics (TSBX) raised $80 million in an initial public offering (IPO) on Friday, July 21st 2023. The company issued 6,666,667 shares at $12.00 per share.

Turnstone Biologics' top institutional investors include Deltec Asset Management LLC (0.46%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Turnstone Biologics investors own include Cara Therapeutics (CARA), JPMorgan Chase & Co. (JPM), Avino Silver & Gold Mines (ASM), Bank of America (BAC), Intel (INTC) and Taiwan Semiconductor Manufacturing (TSM).

Company Calendar

Last Earnings
8/08/2025
Today
9/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TSBX
CIK
1764974
Fax
N/A
Employees
82
Year Founded
N/A

Price Target and Rating

High Price Target
$0.50
Low Price Target
$0.40
Potential Upside/Downside
+26.8%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-171.86%
Return on Assets
-128.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.33
Quick Ratio
3.70

Sales & Book Value

Annual Sales
$19.31 million
Price / Sales
0.43
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.64 per share
Price / Book
0.55

Miscellaneous

Outstanding Shares
23,140,000
Free Float
15,713,000
Market Cap
$8.21 million
Optionable
Not Optionable
Beta
1.36

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:TSBX) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners